Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

22.2%

2 terminated/withdrawn out of 9 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

Phase 3

4(57.1%)

N/A

2(28.6%)

Phase 2

1(14.3%)

7Total

Phase 3(4)

N/A(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06679634Phase 2Recruiting

Retinoblastoma Phase II Expanded Access Clinical Trial

Role: collaborator

NCT04102371Phase 3Completed

Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis

Role: collaborator

NCT00674388Recruiting

The Pediatric Anesthesia Quality Improvement Project

Role: collaborator

NCT04669288Phase 3Terminated

AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department

Role: collaborator

NCT05444881Not ApplicableSuspended

Boricua Youth Study COVID-19 Coping Intervention Study

Role: collaborator

NCT02669836Not ApplicableCompleted

Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia

Role: collaborator

NCT05977400Phase 3Not Yet Recruiting

NICU Antibiotics and Outcomes (NANO) Follow-up Study

Role: collaborator

NCT03390530Phase 3Withdrawn

Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage

Role: collaborator

NCT04792606Recruiting

Long-Term Outcomes of Hip Interventions for Children With Cerebral Palsy

Role: collaborator

All 9 trials loaded